346 related articles for article (PubMed ID: 6245193)
1. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication.
Wakat MA; Chilton HM; Hackshaw BT; Cowan RJ; Ball JD; Watson NE
J Nucl Med; 1980 Mar; 21(3):203-6. PubMed ID: 6245193
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of acute myocardial infarction with 99mTc-hydroxymethylene diphosphonate (HMDP)].
Miyao K; Takahashi T; Kusuoka S; Kubota Y; Tanimura C; Mineo T; Ohmura M; Taniike K; Yamada C; Nakagawa H
Kaku Igaku; 1984 Feb; 21(2):117-24. PubMed ID: 6471588
[No Abstract] [Full Text] [Related]
6. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
Singh A; Usher M
J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
8. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates.
Logic JR; Meyer-Pavel CM; Blackman J
J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610
[No Abstract] [Full Text] [Related]
10. The specificity of pyrophosphate myocardial scintigrams in patients with prior myocardial infarction: concise communication.
Botvinick EH; Shames DM; Sharpe DN; Klausner SC; Werner JA; Chatterjee K; Parmley WW
J Nucl Med; 1978 Oct; 19(10):1121-5. PubMed ID: 214527
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m pyrophosphate myocardial imaging in acute myocardial infarction: value and limitations.
Ahmad M
Mo Med; 1981 Sep; 78(9):575-8. PubMed ID: 6273708
[No Abstract] [Full Text] [Related]
12. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic, electrocardiographic, and enzymatic diagnosis of perioperative myocardial infarction in patients undergoing myocardial revascularization.
Burdine JA; DePuey EG; Orzan F; Mathur VS; Hall RJ
J Nucl Med; 1979 Jul; 20(7):711-4. PubMed ID: 232148
[TBL] [Abstract][Full Text] [Related]
14. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate.
Bell D; Millar AM; Grayshan R; Muir AL
Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991
[No Abstract] [Full Text] [Related]
15. Use of blood-pool imaging in evaluation of diffuse activity patterns in technetium-99m pyrophosphate myocardial scintigraphy.
Cowley MJ; Mantle JA; Rogers WJ; Russell RO; Rackley CE; Logic JR
J Nucl Med; 1979 Jun; 20(6):496-501. PubMed ID: 231644
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial scintigraphy with Tc 99m-pyrophosphate in patients with acute transmural myocardial infarction, non-transmural infarction and unstable angina].
Dighero H; Lobo G; Canessa J; Soto C; Zepeda F; Sabarots C
Rev Med Chil; 1986 Jun; 114(6):546-51. PubMed ID: 3033790
[No Abstract] [Full Text] [Related]
17. [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy].
Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Sakurai M; Hishida H; Mizuno Y; Takeuchi A; Koga S
J Cardiogr; 1982 Sep; 12(3):699-708. PubMed ID: 6308105
[No Abstract] [Full Text] [Related]
18. [Clinical significance of persistently positive technetium-99m pyrophosphate myocardial scintigrams in patients with acute myocardial infarction].
Nakashima Y; Fukuzaki H; Maeda K; Minamiji K; Kida T; Yoshida Y
Kaku Igaku; 1984 Mar; 21(3):221-9. PubMed ID: 6088866
[No Abstract] [Full Text] [Related]
19. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
20. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction.
Malin FR; Rollo FD; Gertz EW
J Nucl Med; 1978 Oct; 19(10):1111-5. PubMed ID: 722321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
